In the present study, we employed the chemotherapy and radiotherapy resistant human GSC and also glioblastoma SNB19 (PTEN mutant) cells to evaluate the therapeutic efficacy of the combination of miR-30e (a tumor suppressor miR) and PAC (an apoptosis inducing plant-derived polyphenolic compound). This evidence concerns the gene PTEN and neoplasm.